AKT1 and urinary bladder carcinoma: In another report, TRIM26 exerted an oncogenic role in bladder cancer and depletion of TRIM26 in bladder cancer cells slowed down tumor progress by inhibiting Akt/GSK3β/β-catenin pathway [27].